January 2012- Volume 8, Issue 1

January 2012

In this Issue

Tools & Technology

Growth in India

Growth in India

AB SCIEX acquires Labindia’s mass spectrometry division to broaden presence in India

Corning Life Sciences acquires Mediatech

Corning Life Sciences acquires Mediatech

Corning to offer customers a more complete solution to their cell culture and bioprocess needs

Shopping for companies during the holidays

Shopping for companies during the holidays

Agilent Technologies grows life- science business with strategic acquisitions in next-generation sequencing and automated analytical solutions for pharma

An unfolding development

An unfolding development

Expedeon and Protein Discovery join forces to provide advanced products for protein research

Research & Development

A positive outcome for breast cancer patients

A positive outcome for breast cancer patients

Galena Biopharma collaborates with Genentech/Roche, HJF in clinical trials of NeuVax for prevention of breast cancer recurrences

Hands across Kendall Square

Hands across Kendall Square

MIT and Pfizer begin work on new partnership space

The power of three

The power of three

Roche, PTC Therapeutics and the SMA Foundation go after potential treatment for Spinal Muscular Atrophy

Waste not, want not

Waste not, want not

New UCSF, GE Healthcare to collaborate on umbilical cord blood project

Curing from hand to mouth

Curing from hand to mouth

Gilead Sciences acquires Pharmasset for $11 billion in hopes of more quickly advancing oral, non-interferon treatments for HCV

Feature

Rebooted and upgraded - SLAS2012 Show Preview

Rebooted and upgraded - SLAS2012 Show Preview

The merged ALA and SBS groups, now known as SLAS, launch first-ever joint annual meeting

The social side of SLAS2012

The social side of SLAS2012

Events at the show and attractions in San Diego

Omics & Systems Biology

Changing the channel

Changing the channel

UCB acquires ion channel-targeting programs from Lectus Therapeutics

An alternative to whole-genome sequencing

An alternative to whole-genome sequencing

Roche NimbleGen, BGI unveil MHC region capture technology for human disease and biomedical research

Going commercial

Going commercial

Compugen, DiscoveRx form collaboration to commercialize novel peptide ligands for GPCR drug targets

Bruker goes to Korea

Bruker goes to Korea

Company will collaborate with Chungnam National University in Korea to develop reference site on glycomics methods for biopharmaceuticals and biosimilars

Genes that fit everyone

Genes that fit everyone

NIH division paves path toward genomic medicine

Government Watch

Meeting the need for speed

Meeting the need for speed

Draft federal legislation addresses FDA issues, including faster drug approvals

A high-stakes dispute

A high-stakes dispute

U.S. Supreme Court hears oral arguments from Prometheus and Mayo over validity of challenged patent

Genetic testing garners lawmaker’s attention

Genetic testing garners lawmaker’s attention

Texas Congressman hopes to block FDA from increased regulation of laboratory-developed genetic tests

Global News

Good cop, bad cop, market share

Good cop, bad cop, market share

Valeant shows both its amiable and hostile sides with an agreement to acquire Australia’s iNova and a hostile bid to take over U.S. company ISTA Pharmaceuticals

A ‘win, win, win’ for public-private partners

A ‘win, win, win’ for public-private partners

AstraZeneca launches innovative partnership with U.K.’s Medical Research Council for discontinued drug compounds

The appeal of zeal

The appeal of zeal

Elan to join Cambridge in new research center aimed at neurodegenerative diseases

The eyes have it

The eyes have it

Proximagen, Altacor to collaborate on glaucoma treatment

‘The next big thing is already here’

‘The next big thing is already here’

Samsung furthers entrée into growing biosimilars market in $300 million joint venture with Biogen Idec

Diagnostics

Roadmap to theranostics

Roadmap to theranostics

Researchers awarded $3.2 million from NIH Roadmap to pioneer advanced biomolecule discovery technology

Deal aggressively targets oncology Dx

Deal aggressively targets oncology Dx

GSK and Abbott expand collaboration to develop additional companion diagnostic test for several types of cancer

Trauma on their minds, treatment in their thoughts

Trauma on their minds, treatment in their thoughts

Amarantus Biosciences and Banyan Biomarkers announce traumatic brain injury research collaboration

Growing steadily downstream

Growing steadily downstream

Affymetrix to acquire eBioscience for $330 million in plan to expand beyond discovery-based efforts

Editor's Focus

Keeping our resolution to report the news

Keeping our resolution to report the news

From publishing our single newspaper in January 2005 to celebrating our eighth year in 2012, ddn continues to produce many vehicles that disseminate the news.

Commentary

Examining recent approaches to treating solid tumors

Examining recent approaches to treating solid tumors

According to the Centers for Disease Control and Prevention, the top 10 cancer types are in the solid tumor category; today, the priority is likely even higher. Thus, there are clear unmet medical needs, and the development of new, cost-efficient and patient-friendly treatments remain a high priority for both the healthcare community and patients.

Out of Order: Gift horses

Out of Order: Gift horses

A quick Google search for the phrase “outcomes-based medicine” yields results in the tens of thousands. When you look at a lot of these results, however, the focus is on scientific method and not, ironically, on outcomes—which is the point of medicine, isn’t it?
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

March 2024 Issue Front Cover

Latest Issue  

• Volume 20 • Issue 2 • March 2024

March 2024

March 2024 Issue